MedPath

PEEP Resuscitation Trial

Not Applicable
Completed
Conditions
Newborn Resuscitation
Interventions
Device: Upright Resuscitator with PEEP
Device: Upright Resuscitator
Registration Number
NCT02971553
Lead Sponsor
Helse Stavanger HF
Brief Summary

Each year, almost 3 million newborn babies die within their first month of life, often as a consequence of labour complications. Approximately 5% of newborns will not start breathing at birth and need immediate help. The optimal ventilation strategy with liquid-filled lungs has not been determined. Animal studies suggest that assisted ventilation with positive end expiratory pressure (PEEP) improves the aeration of liquid-filled lungs leading to more rapid recovery. However, no large human clinical studies have investigated the clinical responses to assisted ventilation with PEEP in asphyxiated newborns.

Detailed Description

Laerdal Global Health has developed a PEEP valve which has been tested and shown to provide reliable end-expiratory pressures in a manikin model, even with a high mask leak. Whether this PEEP valve provides reliable PEEP in vivo and whether this translates to clinical beneficial outcomes remains to be proven.

The aim is to study whether lung aeration can be improved by adding a device for positive end expiratory pressure (PEEP) to better distend the airways in neonates more than 28 weeks gestation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
330
Inclusion Criteria
  • Neonates who need assisted bag/mask ventilation after birth due to failure to initiate breathing the first 60 seconds after birth.
Exclusion Criteria
  • Babies with major deformities not deemed to be viable.
  • Missing parental consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Upright Resuscitator with PEEPUpright Resuscitator with PEEPVentilation with the Upright Resuscitator with PEEP
Upright ResuscitatorUpright ResuscitatorVentilation with the Upright Resuscitator (without PEEP)
Primary Outcome Measures
NameTimeMethod
Delta heart rate (beats/minute) during each ventilation sequence10 minutes
Secondary Outcome Measures
NameTimeMethod
Neonatal outcome dead versus aliveUp to 24 hours
Time to cessation of ventilationUp to 1 hour
Time to heart rate above 140 beats/minuteUp to 1 hour
Mean ariway pressures givenUp to 1 hour
Time to detection of exhaled CO2 above 1% and 4%Up to 1 hour

Trial Locations

Locations (1)

Haydom Lutheran Hospital, Research Institute

🇹🇿

Haydom, Manyara, Tanzania

© Copyright 2025. All Rights Reserved by MedPath